SPC130
Lenvatíníb, að meðtöldu lenvatíníb mesýlati
Status:
VeittApplication date:
17.11.2015Application published:
15.12.2015Grant published:
15.12.2017
Max expiry date:
21.6.2030Next due date:
31.12.2025Medicine name:
LenvimaMedicine for children:
Yes
Timeline
Today
17.11.2015Application
15.12.2015Publication
15.12.2017Registration
21.12.2025Expires
Marketing license
IS authorization number:
EU/1/15/1002/001; EU/1/15/1002/002Date:
15.6.2015
Foreign authorization number:
EU/1/15/1002Date:
28.5.2015
Owner
Name:
Eisai R&D Management Co., Ltd.Address:
6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1698623
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 23.12.2024
Expires: 21.12.2025
Payer:
Number: 2
Paid: 19.11.2025
Expires: 21.12.2025
Payer: G.H. Sigurgeirsson ehf.
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 10.10.2025